Synovial fibroblasts as accessory cells for staphylococcal enterotoxin-mediated T-cell activation - PubMed (original) (raw)

Synovial fibroblasts as accessory cells for staphylococcal enterotoxin-mediated T-cell activation

M Kraft et al. Immunology. 1995 Jul.

Abstract

Rheumatoid arthritis (RA) is thought to be the result of T-cell-mediated autoimmune phenomena. So far, a critical autoantigen has not been identified. Recently, superantigens have been implied in the pathogenesis of RA. In the present study it was tested whether major histocompatibility complex (MHC) class II-positive synovial fibroblast cells (SFC) function as superantigen-presenting cells. SFC were stimulated with interferon-gamma (IFN-gamma) to express class II antigens; then they were cultivated in the presence of T cells with or without staphylococcal enterotoxins (SE). T-cell activation was measured as proliferation and interleukin-2 (IL-2) production. Depending on the dose and type of SE, activation of T-cell clones and also of peripheral T cells was seen. T-cell activation was inhibited by antibodies to MHC class II antigens and also by antibodies to intracellular adhesion molecule type-1 (ICAM-1). The data suggest that class II-positive SFC have the capacity to serve as accessory cells for superantigen-mediated T-cell activation. Thus SFC may participate in the propagation of a T-cell dependent immune response.

PubMed Disclaimer

References

    1. Proc Natl Acad Sci U S A. 1976 Mar;73(3):945-9 - PubMed
    1. Arthritis Rheum. 1983 Nov;26(11):1321-32 - PubMed
    1. J Clin Invest. 1984 Jan;73(1):211-5 - PubMed
    1. J Immunol. 1984 Sep;133(3):1230-4 - PubMed
    1. J Immunol. 1985 Dec;135(6):3750-62 - PubMed

MeSH terms

Substances

LinkOut - more resources